EUVIMEDEUVIMED entdecken
Crossref

Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma

Wenqing Zou, Bingyue Huo, Yaqin Tu, Yuhe Zhu, Yuwei Hu, Qianru Li, Xuan Yu, Bo Liu, Wei Tang, Songwei Tan, Hongjun Xiao

Acta Biomaterialia · 2025

DOI: 10.1016/j.actbio.2025.04.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Wenqing Zou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Immunotherapy, Nanoparticles, Cisplatin. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic effects of platinum-based drugs are closely linked to the dysregulation of tumor metabolic-immune microenvironment, particularly aberrant lactate accumulation. Herein, we engineered multifunctional nanoparticles (PPPtIV NPs) through electrostatic self-assembly of poly(β-amino ester) to co-encapsulate a cisplatin prodrug (PtIV) and CRISPR/Cas9-PKM2 plasmids. Mechanistically, PPPtIV NPs efficiently entered cells via endocytosis, followed by escape from lysosomal degradation and cargo release. The reduction of PtIV prodrug to active PtII via GSH depletion induced DNA damage and ROS upregulation, thereby triggering apoptosis. Concurrently, CRISPR/Cas9-mediated PKM2 knockdown suppressed the Warburg effect, resulting in reduced lactate production and downregulated expression of HIF-1α and PD-L1. These alterations drove immune microenvironment remodeling through enhanced dendritic cell maturation, polarized M1 macrophages, and altered cytokine profiles (characterized by upregulation of IFN-γ, TNF-α, and IL-12 alongside suppression of IL-10), ultimately activating T cell-mediated antitumor immunity. Compared to conventional cisplatin, PPPtIV NPs demonstrated superior efficacy against both primary and recurrent tumors while reducing nephrotoxicity through synergistic chemo-immunotherapeutic effects, offering a valuable strategy for HNSCC treatment. STATEMENT OF SIGNIFICANCE: This study engineered an innovative nanoplatform (PPPtIV) that synergistically integrates a PtIV prodrug with a CRISPR/Cas9-PKM2 plasmid for treating head and neck squamous cell carcinoma. By simultaneously enhancing DNA damage and reversing lactate-mediated immunosuppression, PPPtIV nanoplatform achieved chemo-immunotherapy that showed greater suppression of primary and recurrent tumors with reduced renal toxicity compared to cisplatin. This nanotechnology-driven strategy provides valuable insights into the combination of platinum-based drugs with immunometabolic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckImmunotherapyNanoparticlesCisplatinHead and Neck NeoplasmsGene Transfer TechniquesHumansAnimalsCell Line, TumorProdrugsMiceCRISPR-Cas SystemsTumor MicroenvironmentMetabolic Reprogramming

Stichwörter der Autor:innen

Chemo-gene nanoparticleChemo-immunotherapyCisplatin prodrug (Pt(IV))LactateMetabolic-immune reprogramming

Substanzen

CisplatinProdrugs

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
  • School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Institute of Otorhinolaryngology-Head and Neck Surgery, Tongji Medical Colle…
  • School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: tansongwei@gmail.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zou, W., Huo, B., Tu, Y., Zhu, Y., Hu, Y., Li, Q., Yu, X., Liu, B., Tang, W., Tan, S., & Xiao, H. (2025). Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2025.04.031

Vancouver

Zou W, Huo B, Tu Y, Zhu Y, Hu Y, Li Q, et al. Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2025.04.031

BibTeX
@article{Zou2025,
  author = {Zou, Wenqing and Huo, Bingyue and Tu, Yaqin and Zhu, Yuhe and Hu, Yuwei and Li, Qianru and Yu, Xuan and Liu, Bo and Tang, Wei and Tan, Songwei and Xiao, Hongjun},
  title = {Metabolic reprogramming by chemo-gene co-delivery nanoparticles for chemo-immunotherapy in head and neck squamous cell carcinoma},
  journal = {Acta Biomaterialia},
  year = {2025},
  doi = {10.1016/j.actbio.2025.04.031}
}
Kostenlos starten →